La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Blue Jet Healthcare Résultats passés
Passé contrôle des critères 2/6
Blue Jet Healthcare has been growing earnings at an average annual rate of 3.7%, while the Pharmaceuticals industry saw earnings growing at 15.4% annually. Revenues have been declining at an average rate of 8.1% per year. Blue Jet Healthcare's return on equity is 18.6%, and it has net margins of 22.6%.
Informations clés
3.7%
Taux de croissance des bénéfices
3.7%
Taux de croissance du BPA
| Pharmaceuticals Croissance de l'industrie | 17.5% |
| Taux de croissance des recettes | -8.1% |
| Rendement des fonds propres | 18.6% |
| Marge nette | 22.6% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Revenue Miss: Blue Jet Healthcare Limited Fell 13% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Aug 10
Blue Jet Healthcare Limited's (NSE:BLUEJET) Price In Tune With Earnings
Jul 26Blue Jet Healthcare's (NSE:BLUEJET) Solid Earnings May Rest On Weak Foundations
Jun 02Blue Jet Healthcare Limited Just Missed Earnings - But Analysts Have Updated Their Models
May 30Ventilation des recettes et des dépenses
Comment Blue Jet Healthcare gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 6,950 | 1,574 | 552 | 0 |
| 31 Mar 24 | 7,116 | 1,638 | 532 | 0 |
| 31 Dec 23 | 7,449 | 1,748 | 503 | 0 |
| 30 Sep 23 | 7,471 | 1,802 | 484 | 0 |
| 30 Jun 23 | 7,560 | 1,763 | 454 | 0 |
| 31 Mar 23 | 7,210 | 1,600 | 419 | 0 |
| 31 Mar 22 | 6,835 | 1,816 | 330 | 0 |
| 31 Mar 21 | 4,989 | 1,384 | 290 | 0 |
| 31 Mar 20 | 5,382 | 1,448 | 239 | 0 |
Des revenus de qualité: BLUEJET has high quality earnings.
Augmentation de la marge bénéficiaire: BLUEJET's current net profit margins (22.6%) are lower than last year (23.3%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: BLUEJET's earnings have grown by 3.7% per year over the past 5 years.
Accélération de la croissance: BLUEJET's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: BLUEJET had negative earnings growth (-10.7%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (19.3%).
Rendement des fonds propres
ROE élevé: BLUEJET's Return on Equity (18.6%) is considered low.